| __timestamp | Biogen Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2232342000 | 72471000 |
| Thursday, January 1, 2015 | 2113100000 | 89204000 |
| Friday, January 1, 2016 | 1947900000 | 106010000 |
| Sunday, January 1, 2017 | 1935500000 | 137905000 |
| Monday, January 1, 2018 | 2106300000 | 159888000 |
| Tuesday, January 1, 2019 | 2374700000 | 158425000 |
| Wednesday, January 1, 2020 | 2504500000 | 200677000 |
| Friday, January 1, 2021 | 2674300000 | 304759000 |
| Saturday, January 1, 2022 | 2403600000 | 377221000 |
| Sunday, January 1, 2023 | 2549700000 | 336361000 |
Unlocking the unknown
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Biogen Inc. and Supernus Pharmaceuticals, Inc. have demonstrated contrasting strategies in optimizing these costs. From 2014 to 2023, Biogen's SG&A expenses fluctuated, peaking in 2021 with a 38% increase from 2014. Meanwhile, Supernus Pharmaceuticals showed a more consistent upward trend, with a remarkable 364% rise over the same period.
Biogen's strategic cost management reflects its focus on maintaining a robust market position, while Supernus's increasing expenses highlight its aggressive growth strategy. As the biotech industry evolves, these companies' approaches to SG&A optimization offer valuable insights into balancing growth and efficiency. Investors and industry analysts should closely monitor these trends to understand the financial health and strategic direction of these biotech leaders.
Eli Lilly and Company vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? AbbVie Inc. or Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Novartis AG and Biogen Inc.
Breaking Down SG&A Expenses: Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Biogen Inc.
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Biogen Inc. vs Ionis Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Insmed Incorporated or Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Pharming Group N.V. or Supernus Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Supernus Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.